251 related articles for article (PubMed ID: 7706807)
1. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
Binley JM; Klasse PJ; Cao Y; Jones I; Markowitz M; Ho DD; Moore JP
J Virol; 1997 Apr; 71(4):2799-809. PubMed ID: 9060635
[TBL] [Abstract][Full Text] [Related]
4. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
[TBL] [Abstract][Full Text] [Related]
6. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
7. Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1.
Geffin RB; Scott GB; Melenwick M; Hutto C; Lai S; Boots LJ; McKenna PM; Kessler JA; Conley AJ
AIDS Res Hum Retroviruses; 1998 May; 14(7):579-90. PubMed ID: 9591712
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
9. Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial.
Kahn JO; Steimer KS; Baenziger J; Duliege AM; Feinberg M; Elbeik T; Chesney M; Murcar N; Chernoff D; Sinangil F
J Infect Dis; 1995 May; 171(5):1343-7. PubMed ID: 7751714
[TBL] [Abstract][Full Text] [Related]
10. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
11. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
Robert-Guroff M; Roilides E; Muldoon R; Venzon D; Husson R; Marshall D; Gallo RC; Pizzo PA
J Infect Dis; 1993 Mar; 167(3):538-46. PubMed ID: 7680059
[TBL] [Abstract][Full Text] [Related]
13. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
[TBL] [Abstract][Full Text] [Related]
14. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
16. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
17. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.
Visco-Comandini U; Hultgren C; Broström C; Birk M; Kim S; Sällberg M
Clin Diagn Lab Immunol; 1998 Jul; 5(4):463-6. PubMed ID: 9665949
[TBL] [Abstract][Full Text] [Related]
20. Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
Strathdee SA; Frank JW; McLaughlin J; Leblanc M; Major C; O'Shaughnessy MV; Read SE
J Infect Dis; 1995 Nov; 172(5):1375-9. PubMed ID: 7594682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
